JUN and breast cancer: Interestingly, the CTCF itself has been implicated in affecting the “estrogen receptor α1; ESR1,” which is a crucial factor in both normal breast development and BC [57], and the CJUN has been associated with cell proliferation, angiogenesis, cell cycle progression, and lower survival rate [58,59].